The Novabateans latest stock offering is a milestone in the life of Novabays pharmaceuticals company.The stock was on the verge ...
Innovative marketing programs for the pharmaceutical industry
Innovative marketing programs for the pharmaceutical industry
The Novabateans latest stock offering is a milestone in the life of Novabays pharmaceuticals company.The stock was on the verge ...
Citius Pharmaceuticals (CIV) stock dropped nearly 10% on Wednesday after the company announced it was recalling all its products from ...
It’s hard to believe, but Dicerca’s drug trial is nearly complete. The trial, which was initiated last November, has seen the ...